Project Grant HT9425261E427
- Federal Project Grant Award Summary Psyonic Inc., a minority-owned small disadvantaged business based in San Diego, California, received a $2.635 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 30, 2025, with a completion date of September 29, 2027. The award supports research and development of high-channel intramuscular and intrafascicular electrodes designed for transradial...
- Federal Project Grant Award Summary Onward Medical Inc. received a $325,142 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a clinical-grade spinal cord neuroprosthesis designed to alleviate locomotor deficits in individuals with Parkinson's disease. The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research and technology development relevant to military and public...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- Federal Project Grant Award Summary Tietronix Software Inc., a minority-owned small disadvantaged business based in Houston, Texas, was awarded $520,993.00 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Artificially Intelligent Combat Medical Assistant." The award, effective September 1, 2025, through August 31, 2027, funds the development of an artificial intelligence-enabled medical assistant designed to...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded The Cleveland Clinic Foundation a $1,448,174 Project Grant on June 1, 2024 to fund research on "INTUITIVE ULTRASOUND-BASED UPPER LIMB PROSTHETIC CONTROL AND FEEDBACK UTILIZING TARGETED REINNERVATION FOR NEUROMA PAIN." The research, conducted in collaboration with the University of California, Davis as a sub-awardee, aims to establish sonomyographic control parameters for patients with...
- Federal Grant Award Summary Liberate Medical LLC received a $3.92 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), with an award date of September 15, 2025, and a completion date of September 14, 2029. The project, titled "Abdominal Function Electrical Stimulation to Improve Cough Peak Flow After Spinal Cord Injury: A Randomized Controlled Trial," will be performed in Crestwood, Kentucky. This...
- Federal Project Grant Award Summary Vascular Perfusion Solutions Inc. received an $818,337 Project Grant award dated August 15, 2025, from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports research and development of extended limb stasis capabilities within the ENCORE Tissue Preservation Device, with performance through August 14, 2027, at the awardee's San Antonio, Texas facility. This modification to the existing award...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Veterans Bio-Medical Research Institute Inc. a $1.64 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective November 1, 2026, through October 31, 2030. The grant funds research investigating time-efficient, high-resistance inspiratory muscle training as a therapeutic intervention to address exertional dyspnea (shortness of breath during physical activity) in deployed...
- Federal Project Grant Award Summary General Dynamics Information Technology, Inc. received a $1,247,189 project grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through October 31, 2028. The award funds the TIME (Treatment Interventions for the Mental Health Needs of Warfighters with Traumatic Brain Injury) study, a four-year research initiative evaluating remotely supervised transcranial direct...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $140,000 under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, effective September 1, 2026 through August 31, 2027. This one-year project grant funds research on "Enhancing TIL Trafficking via Paired Cell Engineering and Lipid Nanoparticle Modulation of the Tumor Microenvironment in Mucosal Melanoma," with research activities conducted...
Infinite Biomedical Technologies, LLC (I.b.t.), a minority-owned prosthetic technology firm based in Baltimore, Maryland, received a $3.01 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning August 1, 2026, with an anticipated completion date of July 31, 2030. The award supports research and development focused on optimization of the glide control strategy for individuals with partial hand limb loss—an innovation directly aligned with the DHA's mission to advance medical solutions addressing Service Member health and quality of life. Under this four-year funding period, I.b.t. will leverage its expertise in advanced prosthetic control systems and rehabilitation technologies to develop and refine glide control methodologies that enhance prosthetic functionality for upper-limb amputees, particularly within the veteran population. This research contributes to the broader Military Medical Research and Development portfolio, which emphasizes innovative biomedical solutions for conditions affecting military personnel. The project builds upon I.b.t.'s demonstrated track record in federal prosthetic research, including prior DHA funding for investigating long-term stability of glide control strategies and collaborative work with institutions such as Johns Hopkins University on prosthetic control innovation.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.0m | 7/28/26 |